← Daily Brief
The Bell BriefFrom Dr. Jennifer Bell, DDS
MEDIUMResearchTier 1

The Adjunctive Use of MSC Secretome for Guided Bone Regeneration: An Experimental In Vivo Investigation

SourceClinical Oral Implants ResearchTier 1Peer-Reviewed Research

By Siddharth Shanbhag, Javier Sanz‐Esporrin, Javier Nuñez, Fernando Luengo, Manuel Toledano‐Osorio, Carina Kampleitner, Patrick Heimel, Barbara Schædl, F. Javier Vela Gonzalez, Samih Mohamed‐Ahmed, Cecilie Gjerde, Reinhard Gruber, Kamal Mustafa, Mariano Sanz

Originally at onlinelibrary.wiley.com

Summary & scoring by The Bell Brief (Dr. Jennifer Bell) using the Drill-Down Protocol (Drill-Down Score) — not the original publisher.

Why it matters for dental

Implantologists and oral surgeons may soon gain a biologic adjunct that accelerates bone fill and reduces healing time in guided bone regeneration (GBR), directly affecting case selection and implant timelines.

Key points

  • Experimental in-vivo study published in Clinical Oral Implants Research (EarlyView) evaluated mesenchymal stem-cell secretome as an adjunct to GBR membranes.
  • Secretome-treated defects showed statistically greater bone volume and faster maturation versus standard GBR controls.
  • If translated to human use, practices could shorten the interval between augmentation and implant placement, improving chair-time utilization and patient acceptance.
  • Current evidence is preclinical; no FDA-approved MSC secretome product for dental GBR exists yet.

Who should care

SpecialistAcademia

Read the original on Clinical Oral Implants Research

Full reporting and any paywall content live on onlinelibrary.wiley.com. We summarize and score; we do not republish.

Open original

Related